Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial-Reference-Cited by-同舟云学术

Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial

Published:2016-10-11 Issue:10 Volume:13 Page:e1002139
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Todd John A.,Evangelou Marina^ORCID,Cutler Antony J.,Pekalski Marcin L.,Walker Neil M.,Stevens Helen E.,Porter Linsey,Smyth Deborah J.,Rainbow Daniel B.,Ferreira Ricardo C.,Esposito Laura^ORCID,Hunter Kara M. D.^ORCID,Loudon Kevin^ORCID,Irons Kathryn^ORCID,Yang Jennie H.,Bell Charles J. M.,Schuilenburg Helen,Heywood James^ORCID,Challis Ben,Neupane Sankalpa^ORCID,Clarke Pamela,Coleman Gillian,Dawson Sarah,Goymer Donna,Anselmiova Katerina^ORCID,Kennet Jane,Brown Judy,Caddy Sarah L.^ORCID,Lu Jia^ORCID,Greatorex Jane,Goodfellow Ian,Wallace Chris^ORCID,Tree Tim I.^ORCID,Evans Mark,Mander Adrian P.,Bond Simon,Wicker Linda S.,Waldron-Lynch Frank^ORCID

Funder

Wellcome Trust

JDRF

National Institute for Health Research

Seventh Framework Programme

Sir Jules Thorn Charitable Trust

Medical Research Council

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference61 articles.